rs894277583
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_001034850.3(RETREG1):c.17C>T(p.Pro6Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,437,160 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001034850.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RETREG1 | NM_001034850.3 | c.17C>T | p.Pro6Leu | missense_variant | 1/9 | ENST00000306320.10 | NP_001030022.1 | |
RETREG1 | XM_011514053.4 | c.17C>T | p.Pro6Leu | missense_variant | 1/10 | XP_011512355.1 | ||
RETREG1-AS1 | NR_109946.1 | n.561+469G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RETREG1 | ENST00000306320.10 | c.17C>T | p.Pro6Leu | missense_variant | 1/9 | 1 | NM_001034850.3 | ENSP00000304642.9 |
Frequencies
GnomAD3 genomes AF: 0.000244 AC: 37AN: 151786Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000395 AC: 26AN: 65808Hom.: 0 AF XY: 0.000313 AC XY: 12AN XY: 38350
GnomAD4 exome AF: 0.0000840 AC: 108AN: 1285266Hom.: 0 Cov.: 29 AF XY: 0.0000807 AC XY: 51AN XY: 631970
GnomAD4 genome AF: 0.000244 AC: 37AN: 151894Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74242
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 03, 2021 | In silico analysis supports that this missense variant does not alter protein structure/function; Reported previously as a homozygous variant in an individual with paclitaxel-induced peripheral neuropathy; however, additional information was not provided (Apellaniz-Ruiz et al., 2016); This variant is associated with the following publications: (PMID: 27582484) - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 03, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 6 of the RETREG1 protein (p.Pro6Leu). This variant is present in population databases (no rsID available, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with RETREG1-related conditions. ClinVar contains an entry for this variant (Variation ID: 538125). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.17C>T (p.P6L) alteration is located in exon 1 (coding exon 1) of the FAM134B gene. This alteration results from a C to T substitution at nucleotide position 17, causing the proline (P) at amino acid position 6 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Neuropathy, hereditary sensory and autonomic, type 2B Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at